Literature DB >> 11359905

The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation.

J T Zilfou1, W H Hoffman, M Sank, D L George, M Murphy.   

Abstract

While the transactivation function of the tumor suppressor p53 is well understood, less is known about the transrepression functions of this protein. We have previously shown that p53 interacts with the corepressor protein mSin3a (hereafter designated Sin3) in vivo and that this interaction is critical for the ability of p53 to repress gene expression. In the present study, we demonstrate that expression of Sin3 results in posttranslational stabilization of both exogenous and endogenous p53, due to an inhibition of proteasome-mediated degradation of this protein. Stabilization of p53 by Sin3 requires the Sin3-binding domain, determined here to map to the proline-rich region of p53, from amino acids 61 to 75. The correlation between Sin3 binding and stabilization supports the hypothesis that this domain of p53 may normally be subject to a destabilizing influence. The finding that a synthetic mutant of p53 lacking the Sin3-binding domain has an increased half-life in cells, compared to wild-type p53, supports this premise. Interestingly, unlike retinoblastoma tumor suppressor protein, MDMX, and p14(ARF), Sin3 stabilizes p53 in an MDM2-independent manner. The ability of Sin3 to stabilize p53 is consistent with the model whereby these two proteins must exist on a promoter for extended periods, in order for repression to be an effective mechanism of gene regulation. This model is consistent with our data indicating that, unlike the p300-p53 complex, the p53-Sin3 complex is immunologically detectable for prolonged periods following exposure of cells to agents of DNA damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359905      PMCID: PMC87060          DOI: 10.1128/MCB.21.12.3974-3985.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation.

Authors:  A Hengstermann; N J Whitaker; D Zimmer; H Zentgraf; M Scheffner
Journal:  Oncogene       Date:  1998-12-03       Impact factor: 9.867

2.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

3.  Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.

Authors:  A Böttger; V Böttger; A Sparks; W L Liu; S F Howard; D P Lane
Journal:  Curr Biol       Date:  1997-11-01       Impact factor: 10.834

Review 4.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

5.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

6.  Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage.

Authors:  L Chen; S Agrawal; W Zhou; R Zhang; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

7.  The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.

Authors:  A L Talis; J M Huibregtse; P M Howley
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

8.  The polyproline region of p53 is required to activate apoptosis but not growth arrest.

Authors:  D Sakamuro; P Sabbatini; E White; G C Prendergast
Journal:  Oncogene       Date:  1997-08-18       Impact factor: 9.867

9.  Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.

Authors:  J Roth; M Dobbelstein; D A Freedman; T Shenk; A J Levine
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

Review 10.  The ubiquitin-proteasome pathway in cancer.

Authors:  V Spataro; C Norbury; A L Harris
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  43 in total

1.  Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor.

Authors:  Hiroko Kawata; Kazuya Yamada; Zhangfei Shou; Tetsuya Mizutani; Takashi Yazawa; Miki Yoshino; Toshio Sekiguchi; Takashi Kajitani; Kaoru Miyamoto
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

2.  Suppression of tumorigenesis by the p53 target PUMA.

Authors:  Michael T Hemann; Jack T Zilfou; Zhen Zhao; Darren J Burgess; Gregory J Hannon; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

3.  Transcriptional repression by p53 promotes a Bcl-2-insensitive and mitochondria-independent pathway of apoptosis.

Authors:  Nelly Godefroy; Sylvina Bouleau; Gaëtan Gruel; Flore Renaud; Vincent Rincheval; Bernard Mignotte; Diana Tronik-Le Roux; Jean-Luc Vayssière
Journal:  Nucleic Acids Res       Date:  2004-08-23       Impact factor: 16.971

4.  The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Authors:  David Dornan; Harumi Shimizu; Lindsay Burch; Amanda J Smith; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Radioprobing the conformation of DNA in a p53-DNA complex.

Authors:  Valeri N Karamychev; Difei Wang; Sharlyn J Mazur; Ettore Appella; Ronald D Neumann; Victor B Zhurkin; Igor G Panyutin
Journal:  Int J Radiat Biol       Date:  2012-06-21       Impact factor: 2.694

6.  mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival.

Authors:  Jan-Hermen Dannenberg; Gregory David; Sheng Zhong; Jaco van der Torre; Wing H Wong; Ronald A Depinho
Journal:  Genes Dev       Date:  2005-07-01       Impact factor: 11.361

7.  NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.

Authors:  Philip Hublitz; Natalia Kunowska; Ulrich P Mayer; Judith M Müller; Kristina Heyne; Na Yin; Claudia Fritzsche; Cecilia Poli; Laurent Miguet; Ingo W Schupp; Leo A van Grunsven; Noëlle Potiers; Alain van Dorsselaer; Eric Metzger; Klaus Roemer; Roland Schüle
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

8.  Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

9.  The C terminus of p53 family proteins is a cell fate determinant.

Authors:  Kelly Lynn Harms; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.

Authors:  Thi T Nguyen; Kyucheol Cho; Sabrina A Stratton; Michelle Craig Barton
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.